ATA288981A - Verfahren zur herstellung von neuen mercaptoacylderivaten von 4-cis-substituierten prolinen - Google Patents

Verfahren zur herstellung von neuen mercaptoacylderivaten von 4-cis-substituierten prolinen

Info

Publication number
ATA288981A
ATA288981A AT812889A AT288981A ATA288981A AT A288981 A ATA288981 A AT A288981A AT 812889 A AT812889 A AT 812889A AT 288981 A AT288981 A AT 288981A AT A288981 A ATA288981 A AT A288981A
Authority
AT
Austria
Prior art keywords
cis
producing new
substituted prolines
mercaptoacyl derivatives
mercaptoacyl
Prior art date
Application number
AT812889A
Other languages
English (en)
Other versions
AT374453B (de
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ATA288981A publication Critical patent/ATA288981A/de
Application granted granted Critical
Publication of AT374453B publication Critical patent/AT374453B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5435—Cycloaliphatic phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0288981A 1980-07-01 1981-06-29 Verfahren zur herstellung von neuen mercaptoacylderivaten von 4-cis-substituierten prolinen AT374453B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/164,985 US4316905A (en) 1980-07-01 1980-07-01 Mercaptoacyl derivatives of various 4-substituted prolines

Publications (2)

Publication Number Publication Date
ATA288981A true ATA288981A (de) 1983-09-15
AT374453B AT374453B (de) 1984-04-25

Family

ID=22596924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0288981A AT374453B (de) 1980-07-01 1981-06-29 Verfahren zur herstellung von neuen mercaptoacylderivaten von 4-cis-substituierten prolinen

Country Status (16)

Country Link
US (1) US4316905A (de)
JP (2) JPS5745155A (de)
AT (1) AT374453B (de)
AU (1) AU543386B2 (de)
BE (1) BE889444A (de)
CA (1) CA1173834A (de)
CH (1) CH651548A5 (de)
DE (1) DE3125744A1 (de)
DK (1) DK291381A (de)
FR (2) FR2491468B1 (de)
GB (1) GB2078733B (de)
IE (1) IE51305B1 (de)
IT (1) IT1137271B (de)
NL (1) NL8103099A (de)
SE (1) SE8104092L (de)
ZA (1) ZA813401B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348944A (en) * 1980-10-23 1994-09-20 Schering Corporation Carboxyalkyl dipeptides
US4374131A (en) * 1981-04-27 1983-02-15 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinyl-alkanoyl compounds
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4416833A (en) * 1981-05-04 1983-11-22 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4432971A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4452791A (en) * 1982-03-15 1984-06-05 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4560681A (en) * 1982-04-22 1985-12-24 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
US4448772A (en) * 1982-04-22 1984-05-15 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
CA1258853A (en) * 1982-04-30 1989-08-29 Rudiger D. Haugwitz Substituted 4-phenoxy prolines
US4468519A (en) * 1982-06-14 1984-08-28 E. R. Squibb & Sons, Inc. Esters of phosphinylalkanoyl substituted prolines
US4470973A (en) * 1982-07-19 1984-09-11 E. R. Squibb & Sons, Inc. Substituted peptide compounds
US4623729A (en) 1982-07-22 1986-11-18 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4621092A (en) * 1982-07-22 1986-11-04 E. R. Squibb & Sons, Inc. Substituted proline compounds, composition and method of use
US4742067A (en) * 1982-07-22 1988-05-03 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4508901A (en) * 1982-08-19 1985-04-02 Eli Lilly And Company Quiuolizine and indolizine enzyme inhibitors
US4404282A (en) * 1982-08-19 1983-09-13 Eli Lilly And Company Process for enzyme inhibitor
US4404281A (en) * 1982-08-19 1983-09-13 Eli Lilly And Company Process for enzyme inhibitors
GR78665B (de) * 1982-08-19 1984-09-27 Lilly Co Eli
US4524212A (en) * 1982-09-27 1985-06-18 E. R. Squibb & Sons, Inc. Acyloxyketone substituted imino and amino acids
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
US4456595A (en) * 1982-12-06 1984-06-26 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy aroly peptides
US4826812A (en) * 1982-12-27 1989-05-02 Schering Corporation Antiglaucoma agent
US4514391A (en) * 1983-07-21 1985-04-30 E. R. Squibb & Sons, Inc. Hydroxy substituted peptide compounds
US4675408A (en) * 1983-08-01 1987-06-23 Eli Lilly And Company Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors
US4594431A (en) * 1983-08-01 1986-06-10 Eli Lilly Company Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors
US4602092A (en) * 1983-09-19 1986-07-22 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates
US4501901A (en) * 1983-09-19 1985-02-26 E. R. Squibb & Sons, Inc. Method for making substituted prolines
US4594199A (en) * 1983-09-19 1986-06-10 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates
EP0187037A3 (de) * 1984-12-21 1988-03-23 Takeda Chemical Industries, Ltd. Piperidinderivate, deren Herstellung und Benützung
US4649147A (en) * 1985-07-08 1987-03-10 G. D. Searle & Co. Treating elastin degradation with 1-(alkenoyl)azacycloalkyl carboxylic acids and derivatives
DE3814663C2 (de) * 1987-05-01 1999-12-02 Squibb & Sons Inc Triphenyler, Verfahren zu seiner Herstellung sowie dessen Verwendung
US4851514A (en) * 1987-05-01 1989-07-25 E. R. Squibb & Sons, Inc. Process for preparing a compound useful in preparing ace inhibitors and intermediate produced thereby
US4937355A (en) * 1989-01-17 1990-06-26 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-substituted-dl-proline derivatives
AU632596B2 (en) * 1989-08-21 1993-01-07 E.R. Squibb & Sons, Inc. Phosphonate substituted amino or imino acids useful as antihypertensives
US7659305B2 (en) * 2002-10-31 2010-02-09 Pfizer Inc. Therapeutic proline derivatives
SE0302381D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts I

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins
US3946000A (en) * 1973-10-31 1976-03-23 Bristol-Myers Company 7-[α-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4116962A (en) * 1976-12-03 1978-09-26 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4108886A (en) * 1977-03-11 1978-08-22 E. R. Squibb & Sons, Inc. Thiopropanoylamino acid derivatives
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
CA1109475A (en) * 1978-07-27 1981-09-22 Miguel A. Ondetti Thiopropanoylamino acid derivatives
JPS584711B2 (ja) * 1978-08-02 1983-01-27 参天製薬株式会社 ピロリジン誘導体
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NL7809120A (nl) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw Werkwijze voor de bereiding van proline-derivaten.
CA1132985A (en) * 1978-12-22 1982-10-05 John Krapcho Ketal and thioketal derivatives of mercaptoacyl prolines
CA1138452A (en) * 1979-01-15 1982-12-28 John Krapcho Carbamate derivatives of mercaptoacyl hydroxy prolines

Also Published As

Publication number Publication date
ZA813401B (en) 1982-06-30
NL8103099A (nl) 1982-02-01
FR2491468B1 (fr) 1985-08-02
FR2491063B1 (de) 1984-12-14
JPS5745155A (en) 1982-03-13
CA1173834A (en) 1984-09-04
DK291381A (da) 1982-01-02
CH651548A5 (fr) 1985-09-30
GB2078733A (en) 1982-01-13
US4316905A (en) 1982-02-23
AU543386B2 (en) 1985-04-18
SE8104092L (sv) 1982-01-02
AU7062181A (en) 1982-01-07
GB2078733B (en) 1984-05-02
FR2491468A1 (fr) 1982-04-09
JPH0233028B2 (de) 1990-07-25
DE3125744A1 (de) 1982-03-04
IT1137271B (it) 1986-09-03
IT8122675A0 (it) 1981-07-01
BE889444A (fr) 1981-12-30
IE51305B1 (en) 1986-11-26
IE811330L (en) 1982-01-01
AT374453B (de) 1984-04-25
FR2491063A1 (fr) 1982-04-02
JPH02191250A (ja) 1990-07-27

Similar Documents

Publication Publication Date Title
AT374453B (de) Verfahren zur herstellung von neuen mercaptoacylderivaten von 4-cis-substituierten prolinen
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
ATA907681A (de) Verfahren zur herstellung von neuen taurinderivaten
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT378957B (de) Verfahren zur herstellung von neuen triazolderivaten
AT375923B (de) Verfahren zur herstellung von neuen indolinonderivaten
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
AT374807B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
AT373895B (de) Verfahren zur herstellung von neuen 7alpha -methoxycephalosporinderivaten
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten
AT376419B (de) Verfahren zur herstellung von neuen n-geschuetzten 4-oxo-azetidin-2-carbonsaeurederivaten
AT378195B (de) Verfahren zur herstellung von neuen ergopeptinderivaten
AT374482B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten
AT368759B (de) Verfahren zur herstellung von neuen steroid-20carbons[ureverbindungen
AT380017B (de) Verfahren zur herstellung von neuen spirobenzofuranon-verbindungen
ATA564480A (de) Verfahren zur herstellung von neuen diglycidyltriazinverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee